SURBRONC EXPECTORANT AMBROXOL 30 mg, scored tablet 30 tablets
Active ingredients: Ambroxol hydrochloride
Commercialized according to BDPM
Scored tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SURBRONC EXPECTORANT AMBROXOL 30 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) (PVC/aluminium et PVC/PVDC/Aluminium) de 30 comprimé(s)
- Marketing authorisation holder
- OPELLA HEALTHCARE FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 23 Apr 1987
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63628253CIP73274040CIP133400932740406Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMBROXOLcomprimé | 30 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.